Expected value of information and decision making in HTA

Health Economics

Volumn 16, Issue 2, 2007, Pages 195-209

  Eckermann, Simon ^a   Willan, Andrew R ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Cost of reversal; Decision making; HTA; Opportunity cost of delay; Optimal trial design; Value of information

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; INFORMATION; PRIORITY JOURNAL; STATISTICAL MODEL; ACCOUNTING; BREECH PRESENTATION; CESAREAN SECTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EXPECTED VALUE OF INFORMATION; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH ECONOMICS; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; MEDICAL INFORMATION; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DIFFUSION OF INNOVATION; HUMANS; INFORMATION DISSEMINATION; MODELS, ECONOMETRIC; RESEARCH DESIGN; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNCERTAINTY;

EID: 33846820176     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1161     Document Type: Article

References (12)

1. Bernanke BS. 1983. Irreversibility, uncertainty and cyclical investment. Quarterly Journal of Economics 98(1): 85-106.
2. Claxton K. 1999. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 18: 341-364.
3. Claxton K, Thompson K. 2001. A dynamic programming approach to efficient clinical trial design. Journal of Health Economics 20: 797-822.
4. Claxton K, Sculpher M, Drummond M. 2002. A rational framework for decision making by the National Institute for Clinical Excellence. Lancet 360: 711-715.
5. Claxton K, Ades AE, Lu G. 2004. Expected value of sample information in medical decision modeling. Medical Decision Making 24: 207-228.
6. Eckermann S, Willan AR. The option value of delay in health technology assessment. CAER 2006 Working Paper 6, University of New South Wales. http://www.caer.unsw.edu.au/CAER_WP_series.html
7. Hutton EK, Kaufman K, Hodnett E et al. 2003. External cephalic version beginning at 34 weeks' gestation vs 37 weeks' gestation: a randomized multicenter trial. American Journal of Obstetrics and Gynecology 189: 245-254.
8. Pindyck RS. 1991. Irreversibility, uncertainty, and investment. Journal of Economic Literature 29(3): 1110-1148.
9. Raiffa H, Schlaiffer R. 1967. Applied Statistics Decision Theory. Wiley Interscience: New York.
10. Schlaiffer R. 1958. Probability and Statistics for Business Decisions. McGraw-Hill: New York.
11. Tirole J. 1988. The Theory of Industrial Organisation. MIT Press: Cambridge Massachusetts, 307-308.
12. Willan AR, Pinto EM. 2005. The value of information and optimal clinical trial design. Statistics in Medicine 24: 1791-1806 (Correction: Statistics in Medicine 2006; 25: 720).